PURPOSE: Aberrant promoter methylation and genomic instability occur frequently during colorectal cancer development. CpG island methylator phenotype (CIMP) has been shown to associate with microsatellite instability, and BRAF mutation and is often found in the right-side colon. Nevertheless, the relative importance of CIMP and chromosomal instability (CIN) for tumorigenesis has yet to be thoroughly investigated in sporadic colorectal cancers. EXPERIMENTAL DESIGN: We determined CIMP in 161 primary colorectal cancers and 66 matched normal mucosae using a quantitative bisulfite/PCR/ligase detection reaction (LDR)/Universal Array assay. The validity of CIMP was confirmed in a subset of 60 primary tumors using MethyLight assay and five independent markers. In parallel, CIN was analyzed in the same study cohort using Affymetrix 50K Human Mapping arrays. RESULTS: The identified CIMP-positive cancers correlate with microsatellite instability (P = 0.075) and the BRAF mutation V600E (P = 0.00005). The array-based high-resolution analysis of chromosomal aberrations indicated that the degree of aneuploidy is spread over a wide spectrum among analyzed colorectal cancers. Whether CIN was defined by copy number variations in selected microsatellite loci (criterion 1) or considered as a continuous variable (criterion 2), CIMP-positive samples showed a strong correlation with low-degree chromosomal aberrations (P = 0.075 and P = 0.012, respectively). Similar correlations were observed when CIMP was determined by MethyLight assay (P = 0.001 and P = 0.013, respectively). CONCLUSION: CIMP-positive tumors generally possess lower chromosomal aberrations, which may only be revealed using a genome-wide approach. The significant difference in the degree of chromosomal aberrations between CIMP-positive and the remainder of samples suggests that epigenetic (CIMP) and genetic (CIN) abnormalities may arise from independent molecular mechanisms of tumor progression.
PURPOSE: Aberrant promoter methylation and genomic instability occur frequently during colorectal cancer development. CpG island methylator phenotype (CIMP) has been shown to associate with microsatellite instability, and BRAF mutation and is often found in the right-side colon. Nevertheless, the relative importance of CIMP and chromosomal instability (CIN) for tumorigenesis has yet to be thoroughly investigated in sporadic colorectal cancers. EXPERIMENTAL DESIGN: We determined CIMP in 161 primary colorectal cancers and 66 matched normal mucosae using a quantitative bisulfite/PCR/ligase detection reaction (LDR)/Universal Array assay. The validity of CIMP was confirmed in a subset of 60 primary tumors using MethyLight assay and five independent markers. In parallel, CIN was analyzed in the same study cohort using Affymetrix 50K Human Mapping arrays. RESULTS: The identified CIMP-positive cancers correlate with microsatellite instability (P = 0.075) and the BRAF mutation V600E (P = 0.00005). The array-based high-resolution analysis of chromosomal aberrations indicated that the degree of aneuploidy is spread over a wide spectrum among analyzed colorectal cancers. Whether CIN was defined by copy number variations in selected microsatellite loci (criterion 1) or considered as a continuous variable (criterion 2), CIMP-positive samples showed a strong correlation with low-degree chromosomal aberrations (P = 0.075 and P = 0.012, respectively). Similar correlations were observed when CIMP was determined by MethyLight assay (P = 0.001 and P = 0.013, respectively). CONCLUSION:CIMP-positive tumors generally possess lower chromosomal aberrations, which may only be revealed using a genome-wide approach. The significant difference in the degree of chromosomal aberrations between CIMP-positive and the remainder of samples suggests that epigenetic (CIMP) and genetic (CIN) abnormalities may arise from independent molecular mechanisms of tumor progression.
Authors: Jairo Rodriguez; Jordi Frigola; Elisenda Vendrell; Rosa-Ana Risques; Mario F Fraga; Cristina Morales; Victor Moreno; Manel Esteller; Gabriel Capellà; Maria Ribas; Miguel A Peinado Journal: Cancer Res Date: 2006-09-01 Impact factor: 12.701
Authors: Zheng Li; Zhen Hang Meng; Raman Chandrasekaran; Wen-Lin Kuo; Colin C Collins; Joe W Gray; Shanaz H Dairkee Journal: Cancer Res Date: 2002-04-01 Impact factor: 12.701
Authors: Karolin Trautmann; Jonathan P Terdiman; Amy J French; Ritu Roydasgupta; Nancy Sein; Sanjay Kakar; Jane Fridlyand; Antoine M Snijders; Donna G Albertson; Stephen N Thibodeau; Frederic M Waldman Journal: Clin Cancer Res Date: 2006-11-01 Impact factor: 12.531
Authors: Ajay Goel; Takeshi Nagasaka; Christian N Arnold; Toru Inoue; Cody Hamilton; Donna Niedzwiecki; Carolyn Compton; Robert J Mayer; Richard Goldberg; Monica M Bertagnolli; C Richard Boland Journal: Gastroenterology Date: 2006-09-20 Impact factor: 22.682
Authors: Takeshi Nagasaka; Hiromi Sasamoto; Kenji Notohara; Harry M Cullings; Masanori Takeda; Keigo Kimura; Takeshi Kambara; Donald G MacPhee; Joanne Young; Barbara A Leggett; Jeremy R Jass; Noriaki Tanaka; Nagahide Matsubara Journal: J Clin Oncol Date: 2004-11-15 Impact factor: 44.544
Authors: Jing Huang; Wen Wei; Jane Zhang; Guoying Liu; Graham R Bignell; Michael R Stratton; P Andrew Futreal; Richard Wooster; Keith W Jones; Michael H Shapero Journal: Hum Genomics Date: 2004-05 Impact factor: 4.639
Authors: James M Amos-Landgraf; Amy A Irving; Cory Hartman; Anthony Hunter; Brianna Laube; Xiaodi Chen; Linda Clipson; Michael A Newton; William F Dove Journal: Proc Natl Acad Sci U S A Date: 2012-01-23 Impact factor: 11.205
Authors: Alexandru V Olaru; Yulan Cheng; Rachana Agarwal; Jian Yang; Stefan David; John M Abraham; Wayne Yu; John H Kwon; Mark Lazarev; Steven R Brant; Michael R Marohn; David F Hutcheon; Noam Harpaz; Stephen J Meltzer; Yuriko Mori Journal: Inflamm Bowel Dis Date: 2011-08-09 Impact factor: 5.325
Authors: Noriko Tanaka; Curtis Huttenhower; Katsuhiko Nosho; Yoshifumi Baba; Kaori Shima; John Quackenbush; Kevin M Haigis; Edward Giovannucci; Charles S Fuchs; Shuji Ogino Journal: Am J Pathol Date: 2010-10-29 Impact factor: 4.307
Authors: Mark L McCleland; Kathryn Mesh; Edward Lorenzana; Vivek S Chopra; Ehud Segal; Colin Watanabe; Benjamin Haley; Oleg Mayba; Murat Yaylaoglu; Florian Gnad; Ron Firestein Journal: J Clin Invest Date: 2016-01-11 Impact factor: 14.808
Authors: Yu-Wei Cheng; Hanna Pincas; Jianmin Huang; Emmanuel Zachariah; Zhaoshi Zeng; Daniel A Notterman; Philip Paty; Francis Barany Journal: Med Oncol Date: 2014-09-27 Impact factor: 3.064
Authors: Yu-Wei Cheng; Kamran Idrees; Richard Shattock; Sajid A Khan; Zhaoshi Zeng; Cameron W Brennan; Philip Paty; Francis Barany Journal: Int J Cancer Date: 2010-08-01 Impact factor: 7.396